Ylvali Gerling och Linn Hägg, MYoroface.
Ylvali Gerling and Linn Hägg, MYoroface.

Facing up to dysphagia

MYoroface is advancing into new markets with their treatment of swallowing disorders. The alumni company is growing and looking for talents.

The past year has been an eventful one for the company’s founders, sisters Ylvali Gerling and Linn Hägg, CEO and marketing and sales director respectively, and their neuro muscular training device, IQoro. In addition to making the product available to a broader audience via their new website and entering the UK market, they also won first place and a preliminary study grant in the innovation-promoting contest, Boost Innovation.

A problem, a solution, many customers, and on the lookout for new employees

– There has never been a simple and effective treatment for dysphagia, nor for common problems such as hiatus hernia, snoring and sleep apnoea. Thanks to IQoro, more people than ever can regain their former quality of life in a natural way, says Ylvali Gerling, CEO for MYoroface.

These are common problems, and it shows, in the great interest from customers and in the results. The company is expanding and looking for new team members.

– We are expanding, looking for new employees, and it is really exciting. We have many incoming requests from many different countries and hope to build a team with people of different backgrounds and experiences to continue this expansion successfully, Ylvali Gerling tells us.

MYoforace is making headway and hiring. You?

 

A boost from Boost Innovation

– We have made great progress this last year and we are now in the process of further developing our product and treatment. Boost Innovation gave us an opportunity to spread a digitalisation challenge to researchers and students all around the world, and we are very pleased with the results. The winning proposal really impressed us and it promises great potential for us in the future, says Ylvali Gerling. In addition, Mary Hägg, the innovator behind IQoro, recently received a research grant of SEK 400,000 which she is sharing with the researchers Thorbjörn Holmlund and Eva Levring Jäghagen. The grant will be used to set up a controlled study to investigate how effective MYoroface’s neuromuscular treatment is for sleep apnoea and snoring.

– It’s great that more studies are being conducted in this area. Previous studies suggest that our method could be efficient in treating conditions other than dysphagia, such as sleep apnoea and snoring. And we believe that it also could be a cost-effcient and simpler way to treat those affected, says Ylvali Gerling.

 


Text by: Johanna Stenmark and Karin Borge Renberg

Photographer: Philippe Rendu

Published: 24 April, 2018



Share article:

Text by:

Photographer:

Published:

Facebook

Johanna Stenmark and Karin Borge Renberg

Philippe Rendu

24 April, 2018